Pfizer upgrades guidance for sales of covid-19 vaccine
![Photo: Michel Euler/AP/Ritzau Scanpix](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13160333.ece/ALTERNATES/schema-16_9/21194558832401-1920x1920we.jpg)
Pfizer is upgrading this year's guidance for sales connected to the company's covid-19 vaccines from USD 26bn to USD 33.5bn, according to the firm's Q2 report.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Sweden phases out AstraZeneca's covid-19 vaccine
For subscribers
Pfizer and Biontech expand study of vaccines for children
For subscribers